查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1720909

2025年全球組織心臟瓣膜市場報告

Tissue Heart Valves Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年組織心臟瓣膜市場規模將穩定成長。預計到 2029 年將成長至 17 億美元，複合年成長率為 2.7%。預測期內的成長歸因於心血管疾病盛行率的上升、無縫線技術的採用率的提高、人口老化的成長、心血管治療需求的增加以及醫療保健投資的增加。預計這段時期的主要趨勢包括技術創新、先進培養系統的發展、影像技術的改進、手術技術的進步以及新興國家醫療保健市場的擴張。

預計未來幾年心血管疾病（CVD）盛行率的上升將推動組織心臟瓣膜市場的成長。心血管疾病（CVD）包括心臟病、中風和高血壓等疾病，是全球最大的死因。造成這種成長的主要原因是不健康的生活方式、人口老化、危險因素的流行、不良飲食、缺乏運動、吸煙、壓力和都市化，所有這些都增加了心臟相關疾病的發生率。組織心臟瓣膜在心血管疾病的治療中發揮著重要作用，它為需要置換術瓣膜的患者提供了生物相容性、耐用性、不易形成血栓的解決方案，最終改善了長期心臟功能並減少了併發症。例如，2024 年 9 月，美國心臟衰竭協會 (HFSA) 報告稱，約有 670 萬 20 歲或以上的美國人患有心臟衰竭協會 (HFSA)，預計到 2030 年這一數字將增加到 870 萬，到 2040 年將增加到 1030 萬，到 2050 萬增加到 1140 萬。心血管疾病負擔的增加推動了對組織心臟瓣膜的需求。

在組織心臟瓣膜市場中營運的公司正專注於技術創新以改善患者的治療效果。例如，2024 年 6 月，愛爾蘭科技公司美敦力公司推出了 Avalus Ultra 瓣膜，這是一款下一代外科主動脈組織瓣膜，旨在提高植入時的易用性並支持患者的長期管理。該瓣膜基於 Avalus 瓣膜十年臨床經驗而開發，具有外形小巧、聚醚醚酮 (PEEK) 基座框架（可實現一致的圓度）以及業界領先的有效開口面積 (EOA)，可改善血液流動。此外，它還包含一個滲透性線圈，以提高未來瓣中瓣手術中的可見度，並確保主動脈瓣狹窄患者的長期耐用性。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 - 市場 - 宏觀經濟情境 宏觀經濟情境包括利率、通膨、地緣政治以及感染疾病和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 世界心臟瓣膜組織 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球組織心臟瓣膜市場：成長率分析
  • 全球組織心臟瓣膜市場表現：規模與成長，2019-2024
  • 全球組織心臟瓣膜市場預測：規模與成長，2024-2029 年，2034 年
  • 全球組織心臟瓣膜總目標市場（TAM）

第6章市場區隔

  • 全球組織心臟瓣膜市場類型、表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 支架組織心臟瓣膜
  • 無支架組織心臟瓣膜
  • 全球組織心臟瓣膜市場（按瓣膜類型、表現和預測）：2019-2024 年、2024-2029 年、2034 年
  • 主動脈
  • 二尖瓣
  • 三尖瓣
  • 肺
  • 全球組織心臟瓣膜市場（依最終使用者、績效及預測）：2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 其他最終用戶
  • 全球組織心臟瓣膜市場支架組織心臟瓣膜細分市場（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 牛
  • 清管閥
  • 全球組織心臟瓣膜市場無支架組織心臟瓣膜細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 牛無支架瓣膜
  • 同種異體瓣膜

第7章 區域和國家分析

  • 全球組織心臟瓣膜市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球組織心臟瓣膜市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 組織心臟瓣膜市場：競爭格局
  • 組織心臟瓣膜市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • LifeNet Health Inc.
  • TTK Healthcare Ltd.
  • Braile Biomedica
  • On-X Life Technologies Inc.
  • Anteris Technologies Ltd.
  • Labcor Laboratorios Ltd.
  • CARDION sro
  • CryoLife Inc.
  • Colibri Heart Valve LLC
  • Foldax Inc.
  • Balance Medical Technologies Co. Ltd.
  • MiCardia Corporation
  • Neovasc Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年組織心臟瓣膜市場：提供新機會的國家
  • 2029年組織心臟瓣膜市場：細分領域帶來新機會
  • 2029年組織心臟瓣膜市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r34168

Tissue heart valves are biological heart valves used in replacement surgeries, designed to function such as natural heart valves as an alternative to mechanical ones.

The primary types of tissue heart valves are stented and stentless valves. Stented tissue heart valves are bioprosthetic valves reinforced with a metal or polymer frame (stent) to provide structural support and simplify implantation during valve replacement procedures. These valves come in various types, including aortic, mitral, tricuspid, and pulmonary valves. They are utilized by multiple end-users, such as hospitals, ambulatory surgical centers, and other medical facilities.

The tissue heart valves market research report is one of a series of new reports from The Business Research Company that provides tissue heart valves market statistics, including the tissue heart valves industry global market size, regional shares, competitors with the tissue heart valves market share, detailed tissue heart valves market segments, market trends, and opportunities, and any further data you may need to thrive in the tissue heart valves industry. This tissue heart valves market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue heart valves market size has grown steadily in recent years. It will grow from $1.48 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth during the historic period can be attributed to the increasing prevalence of lifestyle diseases, rising healthcare expenditures, a growing elderly population, a surge in cardiac and pathological disorders, and the rising incidence of heart diseases.

The tissue heart valves market size is expected to see steady growth in the next few years. It will grow to $1.70 billion in 2029 at a compound annual growth rate (CAGR) of 2.7%. The projected growth in the forecast period can be attributed to the rising prevalence of cardiovascular diseases, the increasing adoption of sutureless procedures, a growing aging population, higher demand for cardiovascular treatments, and increased healthcare investments. Key trends expected during this period include technological innovations, the development of advanced culture systems, improvements in imaging technologies, advancements in surgical techniques, and the expansion of healthcare markets in emerging regions.

The increasing prevalence of cardiovascular diseases (CVDs) is expected to drive the growth of the tissue heart valves market in the coming years. CVDs, which include conditions such as heart attacks, strokes, and hypertension, are among the leading causes of mortality worldwide. This rise is primarily driven by unhealthy lifestyles, aging populations, increased prevalence of risk factors, poor diets, physical inactivity, smoking, stress, and urbanization, all contributing to higher rates of heart-related disorders. Tissue heart valves play a crucial role in treating cardiovascular diseases by offering a biocompatible, durable, and less thrombogenic solution for patients requiring valve replacement, ultimately improving long-term heart function and reducing complications. For example, in September 2024, a report by the Heart Failure Society of America (HFSA) stated that approximately 6.7 million Americans aged 20 and older are living with heart failure (HF), with projections estimating this number to rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. This rising burden of CVDs is fueling the demand for tissue heart valves.

Companies operating in the tissue heart valves market are focusing on technological innovations to improve patient outcomes. For instance, in June 2024, Medtronic plc, an Ireland-based technology company, launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve designed to enhance ease of use during implantation and support long-term patient management. This valve, built on a decade of clinical experience with the Avalus valve, features a low profile, a polyetheretherketone (PEEK) base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) to improve blood flow. Additionally, it includes a radiopaque coil for better visibility in future valve-in-valve procedures, ensuring long-term durability for patients with aortic stenosis.

In February 2024, Foldax Inc., a US-based medical device company, partnered with Dolphin Life Science India LLP to manufacture the Tria polymer mitral surgical heart valve in India. This collaboration enables in-country production and distribution, making advanced heart valve solutions more accessible to patients. Dolphin Life Science India LLP is an India-based life sciences company specializing in heart valve manufacturing and distribution.

Major players in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomedica, On-X Life Technologies Inc., Anteris Technologies Ltd., Labcor Laboratorios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, Neovasc Inc.

North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tissue heart valves report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tissue heart valves market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue heart valves market consists of sales of porcine xenograft valves, bovine pericardial valves, and autograft valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Heart Valves Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue heart valves market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue heart valves ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue heart valves market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Stented Tissue Heart Valves; Stentless Tissue Heart Valves
  • 2) By Valve Type: Aortic; Mitral; Tricuspid; Pulmonary
  • 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Stented Tissue Heart Valves: Bovine Pericardial Valves; Porcine Valves
  • 2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves; Homograft Valves
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Edwards Lifesciences Corporation; LivaNova PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Heart Valves Market Characteristics

3. Tissue Heart Valves Market Trends And Strategies

4. Tissue Heart Valves Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tissue Heart Valves Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tissue Heart Valves PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tissue Heart Valves Market Growth Rate Analysis
  • 5.4. Global Tissue Heart Valves Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tissue Heart Valves Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tissue Heart Valves Total Addressable Market (TAM)

6. Tissue Heart Valves Market Segmentation

  • 6.1. Global Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stented Tissue Heart Valves
  • Stentless Tissue Heart Valves
  • 6.2. Global Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aortic
  • Mitral
  • Tricuspid
  • Pulmonary
  • 6.3. Global Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users
  • 6.4. Global Tissue Heart Valves Market, Sub-Segmentation Of Stented Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine Pericardial Valves
  • Porcine Valves
  • 6.5. Global Tissue Heart Valves Market, Sub-Segmentation Of Stentless Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine Pericardial Stentless Valves
  • Homograft Valves

7. Tissue Heart Valves Market Regional And Country Analysis

  • 7.1. Global Tissue Heart Valves Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tissue Heart Valves Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Heart Valves Market

  • 8.1. Asia-Pacific Tissue Heart Valves Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Heart Valves Market

  • 9.1. China Tissue Heart Valves Market Overview
  • 9.2. China Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Heart Valves Market

  • 10.1. India Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Heart Valves Market

  • 11.1. Japan Tissue Heart Valves Market Overview
  • 11.2. Japan Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Heart Valves Market

  • 12.1. Australia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Heart Valves Market

  • 13.1. Indonesia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Heart Valves Market

  • 14.1. South Korea Tissue Heart Valves Market Overview
  • 14.2. South Korea Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Heart Valves Market

  • 15.1. Western Europe Tissue Heart Valves Market Overview
  • 15.2. Western Europe Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Heart Valves Market

  • 16.1. UK Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Heart Valves Market

  • 17.1. Germany Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Heart Valves Market

  • 18.1. France Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Heart Valves Market

  • 19.1. Italy Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Heart Valves Market

  • 20.1. Spain Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Heart Valves Market

  • 21.1. Eastern Europe Tissue Heart Valves Market Overview
  • 21.2. Eastern Europe Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Heart Valves Market

  • 22.1. Russia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Heart Valves Market

  • 23.1. North America Tissue Heart Valves Market Overview
  • 23.2. North America Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Heart Valves Market

  • 24.1. USA Tissue Heart Valves Market Overview
  • 24.2. USA Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Heart Valves Market

  • 25.1. Canada Tissue Heart Valves Market Overview
  • 25.2. Canada Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Heart Valves Market

  • 26.1. South America Tissue Heart Valves Market Overview
  • 26.2. South America Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Heart Valves Market

  • 27.1. Brazil Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Heart Valves Market

  • 28.1. Middle East Tissue Heart Valves Market Overview
  • 28.2. Middle East Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Heart Valves Market

  • 29.1. Africa Tissue Heart Valves Market Overview
  • 29.2. Africa Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Heart Valves Market Competitive Landscape And Company Profiles

  • 30.1. Tissue Heart Valves Market Competitive Landscape
  • 30.2. Tissue Heart Valves Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Heart Valves Market Other Major And Innovative Companies

  • 31.1. Meril Life Sciences Pvt. Ltd.
  • 31.2. MicroPort Scientific Corporation
  • 31.3. LifeNet Health Inc.
  • 31.4. TTK Healthcare Ltd.
  • 31.5. Braile Biomedica
  • 31.6. On-X Life Technologies Inc.
  • 31.7. Anteris Technologies Ltd.
  • 31.8. Labcor Laboratorios Ltd.
  • 31.9. CARDION s.r.o.
  • 31.10. CryoLife Inc.
  • 31.11. Colibri Heart Valve LLC
  • 31.12. Foldax Inc.
  • 31.13. Balance Medical Technologies Co. Ltd.
  • 31.14. MiCardia Corporation
  • 31.15. Neovasc Inc.

32. Global Tissue Heart Valves Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Heart Valves Market

34. Recent Developments In The Tissue Heart Valves Market

35. Tissue Heart Valves Market High Potential Countries, Segments and Strategies

  • 35.1 Tissue Heart Valves Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tissue Heart Valves Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tissue Heart Valves Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer